A review of molecular mechanisms of the anti-leukemic effects of phenolic compounds in honey

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 15054-15073

  Abubakar, Murtala B ^a   Abdullah, Wan Zaidah ^a   Sulaiman, Siti Amrah ^a   Suen, Ang Boon ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Apoptosis; Cell cycle; Cell growth and proliferation; Honey; Leukemia; Phenolic compounds

Indexed keywords

2' METHOXYFLAVONE; 3,3',4',5,7 PENTAMETHOXYFLAVONE; 5 METHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; ACACETIN; ANTINEOPLASTIC AGENT; APIGENIN; APIGENIN TRIMETHYL ETHER; ASPARAGINASE; CAFFEIC ACID PHENETHYL ESTER; CAFFEOYLQUINIC ACID DERIVATIVE; CHRYSIN; CYTARABINE; DICAFFEOYLQUINIC ACID DERIVATIVE; FAS ANTIBODY; FISETIN; FLAVONE DERIVATIVE; GALANGIN; GENKWANIN; HESPERIDIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; PERFOSFAMIDE; PHENOL DERIVATIVE; QUERCETIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VINCRISTINE; WOGONIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTILEUKEMIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; DNA FRAGMENTATION; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; G1 PHASE CELL CYCLE CHECKPOINT; HONEY; HUMAN; LEUKEMIA; M PHASE CELL CYCLE CHECKPOINT; MONOTHERAPY; NONHUMAN; REVIEW; ANALYSIS; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; HONEY; HUMANS; LEUKEMIA; PHENOLS;

EID: 84870686605     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131115054     Document Type: Review

References (85)

1. Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2008, 127, 2893-2917.
2. Smith, A.; Howell, D.; Patmore, R.; Jack, A.; Roman, E. Incidence of haematological malignancy by sub-type: A report from the haematological malignancy research network. Br. J. Cancer 2011, 105, 1684-1692.
3. Fresco, P.; Borges, F.; Diniz, C.; Marques, M. New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 2006, 26, 747-766.
4. Morse, M.A.; Stoner, G.D. Cancer chemoprevention: Principles and prospects. Carcinog. Oxf. 1993, 14, 1737.
5. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073-2085.
6. Bogdanov, S. The Book of Honey. Available online: http://www.bee-hexagon.net/en/protected-sid-UHJvcG9saXNCb29rMi5wZGY%3D.htm (accessed on 26 June 2012).
7. Gómez-Caravaca, A.M.; Gómez-Romero, M.; Arráez-Román, D.; Segura-Carretero, A.; Fernández-Gutiérrez, A. Advances in the analysis of phenolic compounds in products derived from bees. J. Pharm. Biomed. Anal. 2006, 41, 1220-1234.
8. Viuda-Martos, M.; Ruiz-Navajas, Y.; Fernández-López, J.; Pérez-Álvarez, J.A. Functional properties of honey, propolis, and royal jelly. J. Food Sci. 2008, 73, R117-R124.
9. Erejuwa, O.; Sulaiman, S.; Wahab, M.; Sirajudeen, K.; Salleh, M.; Gurtu, S. Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats. Ann. Endocrinol. 2010, 71, 291-296.
10. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.A.; Salam, S.K.N.; Salleh, M.S.M.; Gurtu, S. Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2011, 12, 829-843.
11. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.A.; Sirajudeen, K.N.S.; Salleh, M.S.M.; Gurtu, S. Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2011, 11, 2056-2066.
12. Jaganathan, S.K.; Mandal, M. Antiproliferative effects of honey and of its polyphenols: A review. J. Biomed. Biotechnol. 2009, doi: 10.1155/2009/830616.
13. Le Marchand, L. Cancer preventive effects of flavonoids-A review. Biomed. Pharmacother. 2002, 56, 296-301.
14. Middleton, E., Jr; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751.
15. Ren, W.; Qiao, Z.; Wang, H.; Zhu, L.; Zhang, L. Flavonoids: Promising anticancer agents. Med. Res. Rev. 2003, 23, 519-534.
16. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.A.; Sirajudeen, K.N.S.; Salleh, M.S.M.; Gurtu, S. Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-Kyoto rats and spontaneously hypertensive rats: Effects of antioxidant (honey) treatment. Int. J. Mol. Sci. 2011, 12, 1888-1907.
17. Kelkel, M.; Jacob, C.; Dicato, M.; Diederich, M. Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. Molecules 2010, 15, 7035-7074.
18. Meeran, S.M.; Katiyar, S.K. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci. 2008, 13, 2191-2202.
19. Schwartz, G.K.; Shah, M.A. Targeting the cell cycle: A new approach to cancer therapy. J. Clin. Oncol. 2005, 23, 9408-9421.
20. Tyson, J.J.; Csikasz-Nagy, A.; Novak, B. The dynamics of cell cycle regulation. Bioessays 2002, 24, 1095-1109.
21. Carnero, A. Targeting the cell cycle for cancer therapy. Br. J. Cancer 2002, 87, 129-133.
22. Nurse, P. A long twentieth century of review the cell cycle and beyond. Cell 2000, 100, 71-78.
23. Beier, R.; Bürgin, A.; Kiermaier, A.; Fero, M.; Karsunky, H.; Saffrich, R.; Möröy, T.; Ansorge, W.; Roberts, J.; Eilers, M. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J. 2000, 19, 5813-5823.
24. Johnston, K.A.; Polymenis, M.; Wang, S.; Branda, J.; Schmidt, E.V. Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation. Mol. Cell. Biol. 1998, 18, 5621-5633.
25. Kiechle, F.L.; Zhang, X. Apoptosis: Biochemical aspects and clinical implications. Clin. Chim. Acta 2002, 326, 27-45.
26. Rich, T.; Allen, R.L.; Wyllie, A.H. Defying death after DNA damage. Nature 2000, 407, 777-783.
27. Debatin, K.M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol. Immunother. 2004, 53, 153-159.
28. Schuler, M.; Green, D. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 2001, 29, 684-688.
29. Schuler, M.; Bossy-Wetzel, E.; Goldstein, J.C.; Fitzgerald, P.; Green, D.R. P53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 2000, 275, 7337-7342.
30. Hengst, L.; Göpfert, U.; Lashuel, H.A.; Reed, S.I. Complete inhibition of Cdk/cyclin by one molecule of p21Cip1. Genes Dev. 1998, 12, 3882-3888.
31. Bogdanov, S.; Martin, P. Honey authenticity: A review. Mitt. Lebensm. Hyg 2002, 93, 232-254.
32. Bogdanov, S. Honey Composition. In The Honey Book. Available online: http://www. bee-hexagon.net/en/protected-sid-NUNvbXBvc2l0aW9uSG9uZXkucGRm.htm (accessed on 28 February 2012).
33. Gheldof, N.; Wang, X.H.; Engeseth, N.J. Identification and quantification of antioxidant components of honeys from various floral sources. J. Agric. Food Chem. 2002, 50, 5870-5877.
34. Haydak, M.; Palmer, L.; Tanquary, M.; Vivino, A. Vitamin content of honeys. J. Nutr. 1942, 23, 581.
35. Kishore, R.K.; Halim, A.S.; Syazana, M.; Sirajudeen, K. Tualang honey has higher phenolic content and greater radical scavenging activity compared with other honey sources. Nutr. Res. 2011, 4, 322-325.
36. Mohamed, M.; Sirajudeen, K.; Swamy, M.; Yaacob, N.S.; Sulaiman, S.A. Studies on the antioxidant properties of Tualang honey of Malaysia. Afr. J. Tradit. Complement. Altern. Med. 2010, 7, 59-63.
37. Perez, R.A.; Iglesias, M.T.; Pueyo, E.; Gonzalez, M.; De Lorenzo, C. Amino acid composition and antioxidant capacity of Spanish honeys. J. Agric. Food Chem. 2007, 55, 360-365.
38. White, J.; Doner, L.W. Honey composition and properties. Beekeep. USA 1980, 335, 82-91.
39. Fauzi, A.N.; Norazmi, M.N.; Yaacob, N.S. Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. Food Chem. Toxicol. 2011, 49, 871-878.
40. Ghashm, A.A.; Othman, N.H.; Khattak, M.N.; Ismail, N.M.; Saini, R. Antiproliferative effect of Tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines. BMC Complement. Altern. Med. 2010, 10, 49.
41. Gribel, N.; Pashinskiä, V. The antitumor properties of honey. Vopr. Onkol. 1990, 36, 704-709.
42. Orsolić, N.; Knezević, A.; Sver, L.; Terzić, S.; Hackenberger, B.K.; Basić, I. Influence of honey bee products on transplantable murine tumours. Vet. Comp. Oncol. 2003, 1, 216-226.
43. Swellam, T.; Miyanaga, N.; Onozawa, M.; Hattori, K.; Kawai, K.; Shimazui, T.; Akaza, H. Antineoplastic activity of honey in an experimental bladder cancer implantation model: In vivo and in vitro studies. Int. J. Urol. 2003, 10, 213-219.
44. Wen, C.T.P.; Hussein, S.Z.; Abdullah, S.; Karim, N.A.; Makpol, S.; Yusof, Y.A.M. Gelam and nenas honeys inhibit proliferation of HT 29 colon cancer cells by inducing DNA damage and apoptosis while suppressing inflammation. Asian Pac. J. Cancer Prev. 2012, 13, 1605-1610.
45. Cai, Y.; Luo, Q.; Sun, M.; Corke, H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci. 2004, 74, 2157-2184.
46. Ferreres, F.; Tomáas-Barberáan, F.A.; Gil, M.A.I.; Tomáas-Lorente, F. An HPLC technique for flavonoid analysis in honey. J. Sci. Food Agric. 1991, 56, 49-56.
47. Yao, L.; Jiang, Y.; Singanusong, R.; Datta, N.; Raymont, K. Phenolic acids and abscisic acid in Australian Eucalyptus honeys and their potential for floral authentication. Food Chem. 2004, 86, 169-177.
48. Yaoa, L.; Jiang, Y.; Singanusong, R.; Datta, N.; Raymont, K. Phenolic acids in Australian Melaleuca, Guioa, Lophostemon, Banksia and Helianthus honeys and their potential for floral authentication. Food Res. Int. 2005, 38, 651-658.
49. Andrade, P.; Ferreres, F.; Gil, M.I.; Tomás-Barberán, F.A. Determination of phenolic compounds in honeys with different floral origin by capillary zone electrophoresis. Food Chem. 1997, 60, 79-84.
50. Robinson, J.P.; Narayanan, P.K.; Carter, W.O. Functional measurements using HL-60 cells. Methods Cell Biol. 1994, 42, 423-436.
51. Trayner, I.D.; Bustorff, T.; Etches, A.E.; Mufti, G.J.; Foss, Y.; Farzaneh, F. Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, α1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate. Leuk. Res. 1998, 22, 537-547.
52. O'Gorman, D.M.; McKenna, S.L.; McGahon, A.J.; Knox, K.A.; Cotter, T.G. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals. Leukemia 2000, 14, 602-611.
53. Gallagher, R.; Collins, S.; Trujillo, J.; McCredie, K.; Ahearn, M.; Tsai, S.; Metzgar, R.; Aulakh, G.; Ting, R.; Ruscetti, F.; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979, 54, 713-733.
54. Klein, E.; Vánky, F.; Ben-Bassat, H.; Neumann, H.; Ralph, P.; Zeuthen, J.; Polliack, A. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int. J. Cancer 1976, 18, 421-431.
55. Harris, P.; Ralph, P. Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines. J. Leukoc. Biol. 1985, 37, 407-422.
56. Hurwitz, R.; Hozier, J.; Lebien, T.; Minowada, J.; Gajl-Peczalska, K.; Kubonishi, I.; Kersey, J. Characterization of a leukemic cell line of the pre-B phenotype. Int. J. Cancer 1979, 23, 174-180.
57. Broggini, M.; Marchini, S.; Galliera, E.; Borsotti, P.; Taraboletti, G.; Erba, E.; Sironi, M.; Jimeno, J.; Faircloth, G.; Giavazzi, R. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4. Leukemia 2003, 17, 52-59.
58. Goto, H.; Yanagimachi, M.; Goto, S.; Takeuchi, M.; Kato, H.; Yokosuka, T.; Kajiwara, R.; Yokota, S. Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia. Anti-Cancer Drugs 2012, 23, 417-425.
59. Goto, H.; Yanagimachi, M.; Kajiwara, R.; Kuroki, F.; Yokota, S. Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells. Leuk. Res. 2007, 31, 1293-1301.
60. Kang, T.; Liang, N. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem. Pharmacol. 1997, 54, 1013-1018.
61. Csokay, B.; Prajda, N.; Weber, G.; Olah, E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 1997, 60, 2157-2163.
62. Lee, T.J.; Kim, O.H.; Kim, Y.H.; Lim, J.H.; Kim, S.; Park, J.W.; Kwon, T.K. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 2006, 240, 234-242.
63. Spagnuolo, C.; Russo, M.; Bilotto, S.; Tedesco, I.; Laratta, B.; Russo, G.L. Dietary polyphenols in cancer prevention: The example of the flavonoid quercetin in leukemia. Ann. NY Acad. Sci. 2012, 1259, 95-103.
64. Bestwick, C.S.; Milne, L.; Duthie, S.J. Kaempferol induced inhibition of HL-60 cell growth results from a heterogeneous response, dominated by cell cycle alterations. Chem. Biol. Interact. 2007, 170, 76-85.
65. Bestwick, C.S.; Milne, L. Influence of galangin on HL-60 cell proliferation and survival. Cancer Lett. 2006, 243, 80-89.
66. Wang, I.K.; Lin-Shiau, S.Y.; Lin, J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer 1999, 35, 1517-1525.
67. Gonzalez-Mejia, M.; Voss, O.; Murnan, E.; Doseff, A. Apigenin-Induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27. Cell Death Dis. 2010, 1, e64.
68. Budhraja, A.; Gao, N.; Zhang, Z.; Son, Y.O.; Cheng, S.; Wang, X.; Ding, S.; Hitron, A.; Chen, G.; Luo, J. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther. 2012, 11, 132-142.
69. Watanabe, K.; Kanno, S.; Tomizawa, A.; Yomogida, S.; Ishikawa, M. Acacetin induces apoptosis in human T cell leukemia Jurkat cells via activation of a caspase cascade. Oncol. Rep. 2012, 27, 204-209.
70. Lee, W.-R.; Shen, S.-C.; Lin, H.-Y.; Hou, W.-C.; Yang, L.-L.; Chen, Y.-C. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca2+-dependent endonuclease. Biochem. Pharmacol. 2002, 63, 225-236.
71. Ding, J.; Polier, G.; Köhler, R.; Giaisi, M.; Krammer, P.H.; Li-Weber, M. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression. J. Biol. Chem. 2012, 287, 641-649.
72. Chen, J.H.; Shao, Y.; Huang, M.T.; Chin, C.K.; Ho, C.T. Inhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells. Cancer Lett. 1996, 108, 211-214.
73. Chen, Y.J.; Shiao, M.S.; Hsu, M.L.; Tsai, T.H.; Wang, S.Y. Effect of caffeic acid phenethyl ester, an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells. J. Agric. Food Chem. 2001, 49, 5615-5619.
74. Jin, U.H.; Song, K.H.; Motomura, M.; Suzuki, I.; Gu, Y.H.; Kang, Y.J.; Moon, T.C.; Kim, C.H. Caffeic acid phenethyl ester induces mitochondria-mediated apoptosis in human myeloid leukemia U937 cells. Mol. Cell. Biochem. 2008, 310, 43-48.
75. Woo, K.J.; Jeong, Y.J.; Park, J.W.; Kwon, T.K. Chrysin-Induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem. Biophys. Res. Commun. 2004, 325, 1215-1222.
76. Wudtiwai, B.; Sripanidkulchai, B.; Kongtawelert, P.; Banjerdpongchai, R. Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines. J. Hematol. Oncol. 2011, 4, 52.
77. Ko, W.; Kang, T.; Lee, S.; Kim, Y.; Lee, B. Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells. Phytother. Res. 2002, 16, 295-298.
78. Cheng, A.C.; Huang, T.C.; Lai, C.S.; Pan, M.H. Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells. Eur. J. Pharmacol. 2005, 509, 1-10.
79. Ghorbani, A.; Nazari, M.; Jeddi-Tehrani, M.; Zand, H. The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: Involvement of PPARγ-dependent mechanism. Eur. J. Nutr. 2012, 51, 1-8.
80. Mishima, S.; Inoh, Y.; Narita, Y.; Ohta, S.; Sakamoto, T.; Araki, Y.; Suzuki, K.M.; Akao, Y.; Nozawa, Y. Identification of caffeoylquinic acid derivatives from Brazilian propolis as constituents involved in induction of granulocytic differentiation of HL-60 cells. Bioorgan. Med. Chem. 2005, 13, 5814-5818.
81. Sghaier, M.B.; Skandrani, I.; Nasr, N.; Franca, M.G.D.; Chekir-Ghedira, L.; Ghedira, K. Flavonoids and sesquiterpenes from Tecurium ramosissimum promote antiproliferation of human cancer cells and enhance antioxidant activity: A structure-activity relationship study. Environ. Toxicol. Pharmacol. 2011, 32, 336-348.
82. Valdés, A.; Simó, C.; Ibáñez, C.; Rocamora-Reverte, L.; Ferragut, J.A.; García-Cañas, V.; Cifuentes, A. Effect of dietary polyphenols on K562 leukemia cells: A foodomics approach. Electrophoresis 2012, 33, 2314-2327.
83. Hagiwara, Y.; Kasukabe, T.; Kaneko, Y.; Niitsu, N.; Okabe-Kado, J. Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. Int. J. Hematol. 2010, 92, 136-143.
84. Del Pozo-Insfran, D.; Percival, S.S.; Talcott, S.T. Açai polyphenolics in their glycoside and aglycone forms induce apoptosis of HL-60 leukemia cells. J. Agric. Food Chem. 2006, 54, 1222-1229.
85. Ninomiya, M.; Nishida, K.; Tanaka, K.; Watanabe, K.; Koketsu, M. Structure-Activity relationship studies of 5,7-dihydroxyflavones as naturally occurring inhibitors of cell proliferation in human leukemia HL-60 cells. J. Natur. Med. 2012, doi:10.1007/s11418-012-0697-0.